财务摘要（报告期）（Anavex Life Sciences Corp）
| 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|
| 每股指标： | |||||||||
| 每股收益EPS基本(元) | -0.11 | -0.60 | -0.47 | -0.33 | -0.17 | -0.62 | -0.44 | -0.28 | -0.14 |
| 每股净资产(元) | 1.65 | 1.73 | 1.80 | 1.81 | 1.73 | 1.83 | 1.93 | 1.97 | 1.92 |
| 每股经营现金净流量(元) | -0.09 | -0.34 | -0.27 | -0.18 | -0.07 | -0.31 | -0.26 | -0.17 | -0.05 |
| 每股现金流量净额(元) | -0.09 | 0.02 | 0.07 | 0.05 | -0.07 | -0.04 | 0.01 | 0.02 | -0.01 |
| 盈利能力： | |||||||||
| 净资产收益率平均(%) | -6.22 | -33.41 | -25.83 | -18.13 | -9.35 | -32.71 | -22.34 | -14.07 | -7.32 |
| 总资产净利率(%) | -5.70 | -30.94 | -24.06 | -16.72 | -8.62 | -30.53 | -20.93 | -13.25 | -6.83 |
| 投入资本回报率ROIC(%) | -224.91 | -1,375.21 | -1,142.57 | -562.89 | -312.69 | -734.98 | -407.58 | -259.33 | -142.64 |
| 收益质量： | |||||||||
| 营业利润／利润总额(%) | 132.28 | 117.39 | 115.60 | 113.53 | 118.41 | 107.07 | 106.45 | 109.33 | 108.03 |
| 资本结构： | |||||||||
| 资产负债率(%) | 8.44 | 8.12 | 7.01 | 8.81 | 8.93 | 6.69 | 5.92 | 5.04 | 6.71 |
| 权益乘数 | 1.09 | 1.09 | 1.08 | 1.10 | 1.10 | 1.07 | 1.06 | 1.05 | 1.07 |
| 产权比率 | 0.09 | 0.09 | 0.08 | 0.10 | 0.10 | 0.07 | 0.06 | 0.05 | 0.07 |
| 流动资产／总资产(%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| 流动负债／负债合计(%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| 归属母公司股东的权益／投入资本(%) | 3,149.25 | 4,219.27 | 4,903.75 | 2,538.10 | 2,844.67 | 4,017.52 | 2,146.70 | 2,195.18 | 2,545.52 |
| 偿债能力： | |||||||||
| 流动比率 | 11.85 | 12.32 | 14.27 | 11.35 | 11.20 | 14.95 | 16.89 | 19.86 | 14.90 |
| 速动比率 | 11.85 | 12.32 | 14.27 | 11.35 | 11.20 | 14.95 | 16.89 | 19.86 | 14.90 |
| 货币资金／流动负债(%) | 1,150.58 | 1,204.91 | 1,400.39 | 1,094.52 | 1,084.11 | 1,460.39 | 1,615.25 | 1,899.89 | 1,435.57 |
| 营业利润／流动负债(%) | -90.38 | -444.84 | -389.89 | -210.91 | -116.12 | -499.20 | -376.42 | -287.98 | -111.35 |
| 经营活动产生的现金流量净额／流动负债(%) | -58.57 | -221.68 | -198.42 | -101.86 | -43.74 | -237.31 | -212.91 | -162.81 | -33.25 |
| 归属母公司股东的权益／负债合计(%) | 1,085.03 | 1,131.74 | 1,327.46 | 1,035.31 | 1,019.97 | 1,395.12 | 1,589.29 | 1,885.80 | 1,390.18 |
| 经营活动产生的现金流量净额／负债合计(%) | -58.57 | -221.68 | -198.42 | -101.86 | -43.74 | -237.31 | -212.91 | -162.81 | -33.25 |
| 营业利润／负债合计(%) | -90.38 | -444.84 | -389.89 | -210.91 | -116.12 | -499.20 | -376.42 | -287.98 | -111.35 |
| 成长能力： | |||||||||
| 总资产同比增长率(%) | -0.20 | 1.10 | -1.50 | -0.68 | -5.43 | -5.51 | -3.72 | 91.78 | - |
| 每股净资产同比增长率(%) | -4.62 | -5.45 | -6.77 | -8.28 | -9.90 | -7.98 | -7.52 | 82.22 | - |
| 总负债同比增长率(%) | -5.68 | 22.71 | 16.56 | 73.72 | 25.83 | -5.42 | 2.27 | 3.96 | - |
| 基本每股收益同比增长率(%) | 35.29 | 3.23 | -6.82 | -17.86 | -21.43 | -14.81 | -12.82 | -16.67 | -16.67 |
| 归属母公司股东的权益同比增长率(%) | 0.33 | -0.45 | -2.64 | -4.63 | -7.68 | -5.52 | -4.08 | 100.77 | - |
| 营业利润同比增长率(%) | 26.59 | -9.36 | -20.73 | -27.23 | -31.22 | -21.39 | -20.01 | -26.66 | -24.77 |
| 股东权益合计同比增长率(%) | 0.33 | -0.45 | -2.64 | -4.63 | -7.68 | -5.52 | -4.08 | 100.77 | - |
| 营运能力： | |||||||||
| 衍生指标： | |||||||||
| 现金及现金等价物净增加额TTM(元) | 143,000.00 | 143,000.00 | 1,866,000.00 | 1,617,812.00 | 124,406.00 | -7,524,507.00 | -2,949,884.00 | -4,360,693.00 | 77,483,217.00 |
| 利润总额TTM(元) | -43,043,000.00 | -43,043,000.00 | -47,498,000.00 | -51,368,128.00 | -52,408,072.00 | -49,758,804.00 | -47,619,427.00 | -45,115,228.00 | -42,977,449.00 |
| 投入资本(元) | 4,305,000.00 | 3,362,000.00 | 2,992,699.00 | 5,719,435.00 | 4,750,074.00 | 3,546,742.00 | 7,021,792.00 | 6,933,592.00 | 5,750,013.00 |
| 经营活动产生的现金流量净额TTM(元) | -29,309,000.00 | -29,309,000.00 | -27,785,000.00 | -25,979,306.00 | -25,380,261.00 | -26,531,166.00 | -24,237,864.00 | -27,868,437.00 | -28,335,890.00 |
| 归属母公司净利润TTM(元) | -43,155,000.00 | -43,155,000.00 | -47,505,000.00 | -51,649,373.00 | -52,736,738.00 | -50,067,270.00 | -47,977,919.00 | -45,405,725.00 | -43,218,525.00 |
| 所得税TTM(元) | 112,000.00 | 112,000.00 | 7,000.00 | 281,245.00 | 328,666.00 | 308,466.00 | 358,492.00 | 290,497.00 | 241,076.00 |